ライフサイエンスコーパス: trials have

1 At 14 weeks, patients in the combined trials had a mean change from baseline in LDL cholesterol lev

2 The 156 trials had a median sample size of 91.5 (range, 13-2593) pati

3 Several clinical trials have already demonstrated that combinations of nonchem

4 Grave faults in design and conduct of clinical trials have also substantially contributed to the failure of

5 Unfortunately, these trials have been designed without a strong foundational knowl

6 No large trials have been done to investigate the efficacy of an inter

7 An unprecedented number of trials have been done, initiated, or are planned to test new

8 cirrhosis, but no adequately powered randomised controlled trials have been done.

9 ive in specific Ph-like ALL subsets, and precision medicine trials have been initiated for this high-risk ALL subset.

10 Existing clinical trials have been limited by short duration, low doses of vita

11 yet been conclusively determined as no randomized clinical trials have been published on this issue, and their effective

12 However, trials have been relatively scarce and limited in sample size

13 Few randomized trials have compared disease-free survival outcomes for surgi

14 All three trials have completed 2 years of follow-up.

15 Randomized trials have demonstrated increased morbidity with liberal flu

16 Recent exploratory subgroup analyses of the large phase 3 trials have demonstrated that patients with chronic hepatitis

17 Recent clinical trials have demonstrated that the immense majority of acute p

18 Randomized controlled trials have demonstrated that the newest latent tuberculosis

19 Clinical trials have demonstrated the clinical efficacy of early ART;

20 first- and second-generation EGFR TKI, and recent clinical trials have documented their efficacy in patients with EGFR-m

21 es in cardiovascular medicine fueled by innovative clinical trials have dramatically improved the lives of patients world

22 Purpose Two previous single-arm trials have drawn conflicting conclusions regarding the activ

23 Clinical trials have established the average benefit of cardiac resync

24 The successes and failures of biologics in clinical trials have facilitated our ability to better understand whic

25 However, meta-analyses of vitamin D supplementation trials have failed to show clear improvements in blood pressu

26 Although case series and controlled prospective trials have found the procedure to be safe, it is unclear whe

27 SWOG treatment trials have had a substantial impact on population survival f

28 Clinical trials have investigated the effects of agents designed to ta

29 blood cells can be stored for up to 6 weeks, but randomized trials have not assessed the effects of this final week of st

30 relatively rare disorder, and as such, large-scale clinical trials have not been completed, rendering management decision

31 However, prior OXT treatment trials have produced equivocal results, perhaps because of va

32 However, clinical trials have produced inconsistent results.

33 Recent trials have produced promising results for HSCT and mesenchym

34 Successes achieved in both animal models and human clinical trials have proven ASOs both safe and effective.

35 esults from large cohort studies and randomized, controlled trials have provided conflicting messages about the benefits

36 Recent trials have provided evidence of benefit in reduction of card

37 No high-quality trials have provided evidence of effectiveness and cost-effec

38 Recently, 3 randomized controlled trials have published contradictory conclusions.

39 al infarction (STEMI) has been widely used; however, recent trials have questioned its value and safety.

40 mprove outcomes for patients with hepatorenal syndrome, but trials have reported variable efficacy.

41 Dengue vaccine trials have revealed deficits in our understanding of the mec

42 Clinical trials have showed no relationship between nonsteroidal anti-

43 Clinical trials have shown cardiovascular benefits and potential risks

44 Clinical trials have shown that administration of the nematode Trichur

45 Recent trials have shown that avoiding peanuts during infancy increa

46 However, to date, no randomized clinical trials have studied this proposition.

47 Data from previous trials have suggested that patients receiving clopidogrel mon

48 ds to oligodendrocyte death and demyelination, and clinical trials have tested glial transplants to promote myelin repair

49 Eligible trials had to start randomisation on or after Jan 1, 1970, an

50 However, prospective clinical trials have yet to demonstrate significant efficacy.